Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fiorucci S et al. – The development of dual FXR and TGR5 ligands could provide new opportunities for the treatment of lipid and glucose disorders.

Related Articles

Glucose Tolerance in Depressed Inpatients, under Treatment with Mirtazapine and in Healthy Controls
Experimental and Clinical Endocrinology & Diabetes, 10/21/09    Relevance Score: 66%

Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome
Diabetes Research and Clinical Practice, 11/25/09    Relevance Score: 65%

Fructose-sorbitol ingestion provokes gastrointestinal symptoms in patients with eating disorders
World Journal of Gastroenterology, 11/13/09    Relevance Score: 65%

Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation
Brain, 11/03/09    Relevance Score: 65%

Beyond Glycemic Control: Treating the Entire Type 2 Diabetes Disorder
Postgraduate Medicine, 10/05/09    Relevance Score: 65%

Today in Basic Science...keeping you current

Bupivacaine Inhibits Glutamatergic Transmission in Spinal Dorsal Horn Neurons
Anesthesiology, 12/11/09

Expectations, validity, and reality in pharmacogenetics
Journal of Clinical Epidemiology, 12/11/09

Inhibitory effects of 1,3-thiazine derivatives on melanogenesis
Journal of Pharmacy and Pharmacology, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address